Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
Status:
Completed
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Beclomethasone may be an effective treatment for graft-versus-host disease.
PURPOSE: Phase I/II trial to study the effectiveness of beclomethasone in treating patients
who have graft-versus-host disease of the esophagus, stomach, small intestine, or colon.